Last Update: Aug 19, 2025
Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy
ClinicalTrials.gov Identifier:
Novartis Reference Number:CCTL019A2205B
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.

Study Description

Per Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. lentiviral vectors), long term safety and efficacy follow up of treated patients is required. The purpose of this study is to monitor all patients exposed to CAR-T therapied for 15 years following their last CAR-T (e.g. CTL019) infusion to assess the risk of delayed adverse events (AEs), monitor for replication competent lentivirus (RCL) and assess long-term efficacy, including vector persistence. Patients are enrolled following completion or early discontinuation from a Novartis sponsored or supported study of CAR T-Cell treatment. Patients will be followed for 15 years post treatment from the last treatment. They will be monitored for safety and efficacy within the primary treatment protocols for the protocol defined duration. Patients can drop off treatment protocols at any time to enter this long term Follow up study. Patients discontinuing from the primary treatment protocols for any reason will be enrolled in this long term follow up (LTFU). This will allow collecting data on long term safety and efficacy (as applicable) as mandated by the health authorities of all patients treated with CAR-T therapy within the concept of a single protocol.

Collection of such long term effects of CAR-T cell therapy will help to further define the risk-benefit profile of CAR-T Therapies.

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Phase3
Recruiting
1400
Nov 02, 2015
Feb 22, 2036
All
0 Years - 100 Years (Child, Adult, Older Adult)

Interventions

Genetic

Previously treated CAR-T patients

Lentiviral-based CAR-T cell therapy

Eligibility Criteria

Inclusion Criteria:

* All patients who have received a CAR-T therapy and completed or discontinued early from a Novartis sponsored treatment protocol that utilized CAR-T cells or from any CAR-T trial sponsored by the University of Pennsylvania with which Novartis has a contractual agreement to co-develop the CAR technology.
* Patients who have provided informed consent for the long term follow up study prior to their study participation .

Exclusion Criteria:

* There are no specific exclusion criteria for this study.

Novartis Investigative Site

Recruiting

Melbourne,Victoria,3000,Australia

Novartis Investigative Site

Recruiting

Camperdown,New South Wales,2050,Australia

Novartis Investigative Site

Recruiting

Melbourne,Victoria,3004,Australia

Novartis Investigative Site

Recruiting

Herston,Qld 4006,Australia

Novartis Investigative Site

Recruiting

Murdoch,Western Australia,6150,Australia

Novartis Investigative Site

Recruiting

Vienna,A 1090,Austria

Novartis Investigative Site

Recruiting

Salzburg,5020,Austria

Novartis Investigative Site

Recruiting

Vienna,1090,Austria

Novartis Investigative Site

Recruiting

Ghent,9000,Belgium

Novartis Investigative Site

Recruiting

Hamilton,Ontario,L8v 1c3,Canada

Novartis Investigative Site

Recruiting

Toronto,Ontario,M5g 1x8,Canada

Novartis Investigative Site

Recruiting

Montreal,Quebec,H1t 2m4,Canada

Novartis Investigative Site

Recruiting

Montreal,Quebec,H3t 1c5,Canada

Novartis Investigative Site

Recruiting

Copenhagen,Dk-2100,Denmark

Novartis Investigative Site

Recruiting

Helsinki,00029,Finland

Novartis Investigative Site

Recruiting

Paris,75475,France

Novartis Investigative Site

Recruiting

Paris,75019,France

Novartis Investigative Site

Recruiting

Pierre-Bénite,69495,France

Novartis Investigative Site

Recruiting

Nantes,44093,France

Novartis Investigative Site

Recruiting

Villejuif,94800,France

Novartis Investigative Site

Recruiting

Regensburg,Bayern,93053,Germany

Novartis Investigative Site

Recruiting

Berlin,13353,Germany

Novartis Investigative Site

Recruiting

Hamburg,20246,Germany

Novartis Investigative Site

Recruiting

Cologne,50937,Germany

Novartis Investigative Site

Recruiting

Munich,Bavaria,81377,Germany

Novartis Investigative Site

Recruiting

Ulm,89081,Germany

Novartis Investigative Site

Recruiting

Würzburg,Bavaria,97080,Germany

Novartis Investigative Site

Recruiting

Frankfurt am Main,Hesse,60590,Germany

Novartis Investigative Site

Recruiting

Leipzig,Saxony,04103,Germany

Novartis Investigative Site

Recruiting

Hong Kong,Hong Kong

Novartis Investigative Site

Recruiting

Tel Aviv,6423906,Israel

Novartis Investigative Site

Recruiting

Ramat Gan,5265601,Israel

Novartis Investigative Site

Recruiting

Monza,MB,20900,Italy

Novartis Investigative Site

Recruiting

Roma,RM,00165,Italy

Novartis Investigative Site

Recruiting

Milan,MI,20133,Italy

Novartis Investigative Site

Recruiting

Rozzano,MI,20089,Italy

Novartis Investigative Site

Recruiting

Bologna,BO,40138,Italy

Novartis Investigative Site

Recruiting

Milan,MI,20132,Italy

Novartis Investigative Site

Recruiting

Roma,RM,00168,Italy

Novartis Investigative Site

Recruiting

Fukuoka,Fukuoka,812-8582,Japan

Novartis Investigative Site

Recruiting

Sapporo,Hokkaido,060 8648,Japan

Novartis Investigative Site

Recruiting

Sendai,Miyagi,980 8574,Japan

Novartis Investigative Site

Recruiting

Kyoto,606 8507,Japan

Novartis Investigative Site

Recruiting

Seoul,03722,Korea, Republic of

Novartis Investigative Site

Recruiting

Oslo,0310,Norway

Novartis Investigative Site

Recruiting

Oslo,0424,Norway

Novartis Investigative Site

Recruiting

Singapore,169608,Singapore

Novartis Investigative Site

Recruiting

Seoul,03722,South Korea

Novartis Investigative Site

Recruiting

Seville,Andalusia,41013,Spain

Novartis Investigative Site

Recruiting

Esplugues de Llobregat,Barcelona,08950,Spain

Novartis Investigative Site

Recruiting

Salamanca,Castille and León,37007,Spain

Novartis Investigative Site

Recruiting

Barcelona,Catalonia,08035,Spain

Novartis Investigative Site

Recruiting

Barcelona,08041,Spain

Novartis Investigative Site

Recruiting

Madrid,28009,Spain

Novartis Investigative Site

Recruiting

Madrid,28041,Spain

Novartis Investigative Site

Recruiting

Madrid,28046,Spain

Novartis Investigative Site

Recruiting

Pamplona,Navarre,31008,Spain

Novartis Investigative Site

Recruiting

L'Hospitalet de Llobregat,Barcelona,08907,Spain

Novartis Investigative Site

Recruiting

Valencia,46010,Spain

Novartis Investigative Site

Recruiting

Taipei,10002,Taiwan

Novartis Investigative Site

Recruiting

London,Se5 9rs,United Kingdom

Novartis Investigative Site

Recruiting

Birmingham,B15 2th,United Kingdom

Emory University School of Medicine-Winship Cancer Institute

Recruiting

Atlanta,Georgia,30322,United States

Jonathon Cohen
Keshawna L. Sherer
Sharah Triplett

Uni of Chi Medi Ctr Hema and Onco

Recruiting

Chicago,Illinois,60637,United States

Howie Weiner
Linda Schroeder
Michael R Bishop
Michael R. Bishop

University of Kansas Cancer Center

Recruiting

Westwood,Kansas,66205,United States

Janie Smart
Joseph P McGuirk
Maghen Farris

Beth Israel Deaconess Med Center

Recruiting

Boston,Massachusetts,02215,United States

Adam Sperling
Jacalyn Rosenblatt

Uni Of Michigan Health System

Recruiting

Ann Arbor,Michigan,48109,United States

John Magenau
Michelle Smith Tucker
Sabrina Hargrove

Children s Mercy Hospital

Recruiting

Kansas City,Missouri,64108,United States

Allison Miles
Gary D. Myers
Gary Myers, MD
Rachel Wilcox

Duke Unversity Medical Center

Recruiting

Durham,North Carolina,27705,United States

Erin Arbuckle
Kristine Edwards
Nelson Chao
Paul L. Martin

Cinn Children Hosp Medical Center

Recruiting

Cincinnati,Ohio,45229-3039,United States

Kristie Evans Stricker
Melanie Jordan
Stella M. Davies

Oregon Health Sciences University

Recruiting

Portland,Oregon,97239,United States

Beth Zentzis
Brandon Hayes-Lattin
Mai-Lee Lee Yap

The Childrens Hosp of Philadelphia

Recruiting

Philadelphia,Pennsylvania,19104,United States

Kim-Marie Shea
Lauren Vernau
Michelle Caylor
Noelle Frey
Stephan Grupp

UTSW/Children's Medical Center

Recruiting

Dallas,Texas,75235,United States

Alison Patterson
Theodore Laetsch, MD
Theodore Laetsch

MD Anderson Cancer Center

Recruiting

Houston,Texas,77030,United States

Jason Westin
Laura Hargraves
Shapatra Parker
Souzanne T. Ouzounian

University of Utah Clinical Trials Office

Recruiting

Salt Lake City,Utah,84108,United States

Hina Yazdani
Luke Stone
Michael Boyer, MD
Michael Boyer
Michael Pulsipher

University of Wisconsin Hospital

Recruiting

Madison,Wisconsin,53792,United States

Celeste Matsushima
Christian Capitini
Jenny Weiland
Kreg M Grindle

Childrens Hospital Los Angeles

Recruiting

Los Angeles,California,90027,United States

Alan Wayne
Lee Chen

UCSF Medical Center

Recruiting

San Francisco,California,94143,United States

Charalambos Andreadis
Jenai Wilmoth

Stanford University Medical Center

Recruiting

Stanford,California,94304,United States

Christina Baggott
Kara Davis

Childrens Healthcare of Atlanta

Recruiting

Atlanta,Georgia,30342,United States

Audry Grizzle Tumlin
Muna Qayed

University of Michigan

Recruiting

Ann Arbor,Michigan,48109-2800,United States

Gregory Yanik
Sabrina Hargrove

Ohio ST Compr Cancer Ctr James Hosp

Recruiting

Columbus,Ohio,43210,United States

David A Bond
Molly Vittorio

Massachusetts General Hospital

Recruiting

Boston,Massachusetts,02114,United States

Matthew Frigault

City of Hope National Medical Center

Recruiting

Duarte,California,91010 3000,United States

Leslie Popplewell

UCLA Medical Center

Recruiting

Los Angeles,California,90095,United States

Aravind Ramakrishnan

Wayne State University-Karmanos Cancer Institute

Recruiting

Detroit,Michigan,48201,United States

Abhinav Deol

University of Texas Southwestern Medical Center

Recruiting

Dallas,Texas,75390,United States

Cris Molina
Samuel John

Worldwide Contacts

If the location of your choosing does not feature any contact detail, please reach out using the information below.

Novartis Pharmaceuticals

Novartis Pharmaceuticals